Translational Development Acquisition Corp. - *W EXP 12/18/202 (TDACW)
CUSIP: G9008W113
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / *W EXP 12/18/202
- Total 13F shares
- 5,196,582
- Share change
- +5,196,582
- Total reported value
- $954,744
- Price per share
- $0.20
- Number of holders
- 21
- Value change
- +$954,744
- Number of buys
- 21
Quarterly Holders Quick Answers
What is CUSIP G9008W113?
CUSIP G9008W113 identifies TDACW - Translational Development Acquisition Corp. - *W EXP 12/18/202 in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Newer quarter: Q2 2025
Recent filing periods for CUSIP G9008W113:
Top shareholders of TDACW - Translational Development Acquisition Corp. - *W EXP 12/18/202 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| AQR Arbitrage LLC |
13F
|
Company |
8.6%
|
1,485,000
|
$14,894,550 | — | 31 Dec 2024 | |
| Magnetar Financial LLC |
13D/G
13F
|
Company |
7.5%
|
1,300,000
|
$13,325,000 | $0 | 31 Dec 2024 | |
| AQR CAPITAL MANAGEMENT LLC |
13D/G
|
— |
6.4%
|
1,099,989
|
$11,087,889 | -$3,880,911 | 31 Mar 2025 | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND |
13F
13D/G
|
Company |
2.3%
from 13D/G
|
900,000
|
$9,027,000 | — | 31 Dec 2024 | |
| LMR Partners LLP |
13F
|
Company |
4.6%
|
800,000
|
$8,016,000 | — | 31 Dec 2024 | |
| Polar Asset Management Partners Inc. |
13F
|
Company |
4.6%
|
800,000
|
$8,016,000 | — | 31 Dec 2024 | |
| K2 PRINCIPAL FUND, L.P. |
13F
|
Company |
3.9%
|
674,997
|
$6,763,470 | — | 31 Dec 2024 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
3.8%
|
650,000
|
$6,519,500 | — | 31 Dec 2024 | |
| First Trust Capital Management L.P. |
13F
|
Company |
3.8%
|
650,000
|
$6,513,000 | — | 31 Dec 2024 | |
| TENOR CAPITAL MANAGEMENT Co., L.P. |
13F
|
Company |
3.7%
|
635,399
|
$6,366,698 | — | 31 Dec 2024 | |
| LINDEN ADVISORS LP |
13F
|
Company |
3.5%
|
600,000
|
$6,018,000 | — | 31 Dec 2024 | |
| Crossingbridge Advisors, LLC |
13F
|
Company |
3.5%
|
600,000
|
$6,013,000 | — | 31 Dec 2024 | |
| RIVERNORTH CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.9%
|
500,000
|
$5,010,000 | — | 31 Dec 2024 | |
| CSS LLC/IL |
13F
|
Company |
2.3%
|
400,000
|
$4,008,000 | — | 31 Dec 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
2.3%
|
400,000
|
$4,008,000 | — | 31 Dec 2024 | |
| Calamos Advisors LLC |
13F
|
Company |
2.2%
|
375,000
|
$3,761,250 | — | 31 Dec 2024 | |
| Shaolin Capital Management LLC |
13F
|
Company |
2.2%
|
375,000
|
$3,757,500 | — | 31 Dec 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
2%
|
350,000
|
$3,510,500 | — | 31 Dec 2024 | |
| MMCAP International Inc. SPC |
13F
|
Company |
2%
|
350,000
|
$3,507,000 | — | 31 Dec 2024 | |
| Verition Fund Management LLC |
13F
|
Company |
2%
|
346,490
|
$3,475,295 | — | 31 Dec 2024 | |
| WOLVERINE ASSET MANAGEMENT LLC |
13F
|
Company |
1.8%
|
310,000
|
$3,106,200 | — | 31 Dec 2024 | |
| Westchester Capital Management, LLC |
13F
|
Company |
1.7%
|
286,180
|
$2,870,386 | — | 31 Dec 2024 | |
| PICTON MAHONEY ASSET MANAGEMENT |
13F
|
Company |
1.4%
|
250,000
|
$2,505,000 | — | 31 Dec 2024 | |
| PERISCOPE CAPITAL INC. |
13F
|
Company |
1.2%
|
200,000
|
$2,004,000 | — | 31 Dec 2024 | |
| DLD Asset Management, LP |
13F
|
Company |
1.1%
|
194,853
|
$1,952,427 | — | 31 Dec 2024 | |
| BERKLEY W R CORP |
13F
|
Company |
1%
|
173,530
|
$1,738,771 | — | 31 Dec 2024 | |
| Schechter Investment Advisors, LLC |
13F
|
Company |
0.87%
|
150,640
|
$1,509,413 | — | 31 Dec 2024 | |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.87%
|
150,000
|
$1,504,500 | — | 31 Dec 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.77%
|
133,325
|
$1,335,917 | — | 31 Dec 2024 | |
| MIZUHO SECURITIES USA LLC |
13F
|
Company |
0.72%
|
125,000
|
$1,243,750 | — | 31 Dec 2024 | |
| Radcliffe Capital Management, L.P. |
13F
|
Company |
0.69%
|
119,539
|
$1,197,781 | — | 31 Dec 2024 | |
| Centiva Capital, LP |
13F
|
Company |
0.58%
|
100,000
|
$1,003,000 | — | 31 Dec 2024 | |
| MOORE CAPITAL MANAGEMENT, LP |
13F
|
Company |
0.58%
|
100,000
|
$1,003,000 | — | 31 Dec 2024 | |
| GLAZER CAPITAL, LLC |
13F
|
Company |
0.58%
|
100,000
|
$1,002,000 | — | 31 Dec 2024 | |
| GRITSTONE ASSET MANAGEMENT LLC |
13F
|
Company |
0.49%
|
85,000
|
$851,700 | — | 31 Dec 2024 | |
| Warberg Asset Management LLC |
13F
|
Company |
0.43%
|
74,462
|
$746,109 | — | 31 Dec 2024 | |
| Yakira Capital Management, Inc. |
13F
|
Company |
0.35%
|
60,000
|
$601,200 | — | 31 Dec 2024 | |
| Wealthspring Capital LLC |
13F
|
Company |
0.34%
|
59,360
|
$594,787 | — | 31 Dec 2024 | |
| CLEAR STREET LLC |
13F
|
Company |
0.34%
|
58,900
|
$590,178 | — | 31 Dec 2024 | |
| Parallax Volatility Advisers, L.P. |
13F
|
Company |
0.29%
|
50,400
|
$505,008 | — | 31 Dec 2024 | |
| Tuttle Capital Management, LLC |
13F
|
Company |
0.14%
|
25,000
|
$250,500 | — | 31 Dec 2024 | |
| FLOW TRADERS U.S. LLC |
13F
|
Company |
0.13%
|
22,500
|
$225,000 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.05%
|
8,180
|
$81,964 | — | 31 Dec 2024 |
Institutional Holders of Translational Development Acquisition Corp. - *W EXP 12/18/202 (TDACW) as of Q1 2025
As of 31 Mar 2025,
Translational Development Acquisition Corp. - *W EXP 12/18/202 (TDACW) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,196,582 shares.
The largest 10 holders included
AQR Arbitrage LLC, Shaolin Capital Management LLC, CSS LLC/IL, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, LMR Partners LLP, Polar Asset Management Partners Inc., Hudson Bay Capital Management LP, TENOR CAPITAL MANAGEMENT Co., L.P., K2 PRINCIPAL FUND, L.P., and Verition Fund Management LLC.
This page lists
21
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2025 Across Filers
Q4 2025 holders
33
Q1 2025 holders
21
Holder diff
-12
| Investor | Q4 2025 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.